COMMUNIQUÉS West-GlobeNewswire

Evelo Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
15/05/2019
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing oral biologics that act on cells in the small intestine with [...]
Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer
15/05/2019
SANTA CLARA, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
resTORbio Reports First Quarter 2019 Financial Results and Corporate Update
15/05/2019
Initiated first Phase 3 trial, PROTECTOR 1, of RTB101 in clinically symptomatic respiratory illness; top-line data from two pivotal Phase 3 trials expected in mid-2020 Initiated Phase 1b/2a trial of RTB101 in [...]
Vericel to Present at the 2019 UBS Global Healthcare Conference on Wednesday, May 22, 2019
15/05/2019
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Langley BC Cannabis Ltd. Launches funding to raise $5 Million from Accredited Investors
15/05/2019
Langley BC Cannabis Ltd. is currently in the early stages of its application to become a medical cannabis producer under Health Canada’s Cannabis Act LANGLEY, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- Langley [...]
Dermavant Sciences Appoints Timothy S. Nelson and Kenneth E. Ludlum to Board of Directors
15/05/2019
LONDON, May 15, 2019 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that Timothy S. Nelson and Kenneth E. Ludlum have been appointed to Dermavant’s Board of [...]
Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain
15/05/2019
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce [...]
Intra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual Meeting
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced the [...]
Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
15/05/2019
Enrollment for Phase 1b Trial of RTX-134 for Phenylketonuria on Track for Second Quarter 2019; Initial Clinical Data Anticipated in Second Half 2019 Company Announces Transition of President Torben Straight Nissen, Ph.D [...]
Establishment Labs Reports First Quarter 2019 Financial Results
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019
15/05/2019
CRANBURY, N.J., May 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported business highlights and financial results for its second fiscal quarter ended March 31, 2019. [...]
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
15/05/2019
- Adaptimmune to license Alpine’s Secreted and Transmembrane Immunomodulatory Protein technology for use with SPEAR T-cells to enhance antitumor responses - PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 15, 2019 ( [...]
BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation
15/05/2019
May 15, 2019 Announcement no. 7 BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation First test focused on risk assessment of Acute Kidney Injury in pediatric patients BioPorto [...]
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
15/05/2019
LAVAL, Québec, May 15, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
VIVUS Partners with HarborPath Direct to Facilitate Access to PANCREAZE® for Patients Without Health Insurance
15/05/2019
CAMPBELL, Calif. and CHARLOTTE, N.C., May 15, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, and HarborPath Direct, Inc., today announced a partnership to facilitate [...]
North Bud Farms Arranges Private Placement Financing and Provides Corporate Update
15/05/2019
- Insiders of NORTHBUD have Committed $1 Million as Lead Order THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN [...]
BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.
15/05/2019
New York, NY, May 15, 2019 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (NASDAQ: BCAC) (“BCAC” or the “Company”) today announced that it has closed its business combination with Xynomic Pharmaceuticals, Inc. (“ [...]
Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational Highlights
15/05/2019
Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT EXTON, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell- [...]
Clearside Biomedical to Present at the UBS Global Healthcare Conference
15/05/2019
ALPHARETTA, Ga., May 15, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Pages